Marvin Sinsakul
Associate Director, Clinical Development AstraZeneca
Seminars
Tuesday 17th March 2026
Optimizing CKD Outcomes Through Fixed-Dose Combination Therapies
11:00 am
- Evaluating clinical rationale for combining complementary mechanisms in a single therapy to improve kidney and cardiovascular outcomes
- Reviewing evidence from recent trials demonstrating efficacy, safety, and tolerability of fixed-dose combinations in CKD populations
- Considering regulatory and formulation challenges for developing multi-agent therapies with predictable pharmacokinetics
- Exploring patient adherence, convenience, and real-world implementation benefits of fixed-dose combination strategies
